| __timestamp | Amicus Therapeutics, Inc. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 47624000 | 22223073 |
| Thursday, January 1, 2015 | 76943000 | 6966842 |
| Friday, January 1, 2016 | 104793000 | 9000499 |
| Sunday, January 1, 2017 | 149310000 | 13741186 |
| Monday, January 1, 2018 | 270902000 | 19040000 |
| Tuesday, January 1, 2019 | 286378000 | 23559000 |
| Wednesday, January 1, 2020 | 308443000 | 31931000 |
| Friday, January 1, 2021 | 272049000 | 44981000 |
| Saturday, January 1, 2022 | 276677000 | 54234000 |
| Sunday, January 1, 2023 | 152381000 | 63806000 |
Unlocking the unknown
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Amicus Therapeutics, Inc. has consistently outpaced Viking Therapeutics, Inc. in R&D investment. From 2014 to 2023, Amicus's R&D expenses surged by over 220%, peaking in 2020. In contrast, Viking's R&D spending, while growing, remained at about 20% of Amicus's peak levels.
Amicus's strategic focus on R&D is evident, with expenditures reaching their zenith in 2020, a year marked by significant advancements in rare disease therapies. Meanwhile, Viking's steady increase in R&D spending, culminating in a 187% rise by 2023, signals its growing ambition in the therapeutic space. This financial commitment underscores the dynamic nature of biotech innovation, where strategic R&D investments can lead to groundbreaking treatments and substantial market shifts.
Research and Development Investment: Alnylam Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Teva Pharmaceutical Industries Limited and Viking Therapeutics, Inc.
Analyzing R&D Budgets: Genmab A/S vs Viking Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Dr. Reddy's Laboratories Limited and Viking Therapeutics, Inc.
Research and Development: Comparing Key Metrics for BioMarin Pharmaceutical Inc. and Viking Therapeutics, Inc.
Blueprint Medicines Corporation vs Viking Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Pharming Group N.V. vs Amicus Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for TG Therapeutics, Inc. and Viking Therapeutics, Inc.
Research and Development Expenses Breakdown: ADMA Biologics, Inc. vs Amicus Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Viking Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated
Analyzing R&D Budgets: Viking Therapeutics, Inc. vs Agios Pharmaceuticals, Inc.
R&D Spending Showdown: Amicus Therapeutics, Inc. vs Iovance Biotherapeutics, Inc.